• Contact
  • Account
Search

EPOS 2025

Abstract submission

Abstract submission

The abstract submission is now closed

General Conditions
  1. Abstracts are required for all oral presentations and e-posters.
  2. Only 2 abstracts per presenter will be accepted for podium presentation.
  3. Abstracts must be submitted in English. No linguistic revision will be made.
  4. Accepted abstracts will be published online in JCO.
  5. By submitting an abstract you consent to giving JCO permission to publish your abstract.
  6. Please note that illustrations, pictures, tables, and references will not be published in the abstract book and will be removed before publication. They will however be considered during the reviewing process. 
  7. Withdrawal of abstracts can only be accepted if notified in writing and subsequently confirmed by the EPOS Reading Committee.
  1. The submitter must include Conflict of Interest (CoI) for all authors. 
  2. The presenting author must register as an active participant at the conference at the latest 14 days after acceptance of an abstract.
  3. EPOS reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration at the latest 14 days after notification on acceptance, with no further notice.
  1. The abstract word limit is max. 300 words per abstract.
  2. The title should be as brief as possible but long enough to clearly indicate the nature of the study.
  3. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.
  4. The abstract must include the following:
    Introduction and Objective: Clearly state the purpose of the abstract.
    Methods: Describe your selection of observations or experimental subjects clearly.
    Results: Present your results in a logical sequence in text, table and illustrations.
    Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
    Significance of study
  5. All abbreviations must be defined in first use.
  6. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
  7. Data previously published will not be accepted.
  8. Do NOT include references, credits, or grant support
  9. Use of brand names: Generic names must be used for all references to products or companies. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only.
    EPOS reserves the right to replace any brand name with a generic name without further notice.

Abstracts can be submitted within the following topics:

  • Basic Science
  • Trauma
  • Spine
  • Hip
  • Lower Limb Deformity
  • Foot & Ankle
  • Sports
  • Upper Limb & Hand
  • Neuromuscular
  • Tumours & Infections
  • Dysplasias, Congenital & Syndromic
  • Miscellanous
  1. The Reading Committee will review the abstract.
  2. Notification of acceptance or rejection of the abstract will be sent directly to all presenting authors by email.
  3. It is the responsibility of all investigators that all studies are performed with respect to national legislation, international legislation and ethical guidelines for medical research involving humans and/or animals. The EPOS Reading Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
  4. Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.

For all inquiries regarding the abstract submission, please contact the Conference Organiser, c/o CAP Partner at: info@cap-partner.eu

Abstract submission status: Closed

SUBMISSION DEADLINE:
1 October 2024, 23:59 CET

Abstract notifications:
20 November 2024

Reviewers

David Farrington, Chair
Illka Helenius, Vice-Chair
Marta Salom, ExCom Councilor
Tristan Langlais, Local Committee
Sebastian Farr, Education Committe Chair
Christian Wong, Scientific Committee Chair
Giovanni Trisolino, Genetics & Metabolism Study Groups Chair
Yrjänä Nietosvaara, Upper Limb Study Group Chair
Ole Rahbek, Lower Limb Study Group Chair
Muharrem Inan, Neuromuscular Study Group
Christina Steiger, Trauma Study Group Chair
Jon Morten Andersen, Trauma Study Group Chair
Nicolas Nicolaou, Sports Study Group
Moyo Kruyt, Spine Study Group Chair
Bartłomiej Kowalczyk, Tumours &Infections Study Group Chair
Andreas Krieg, Tumours & Infections Study Group Chair
Julia Funk, Member
Tanja Kraus, Member

Eva Ponten, Member
Romain Dayer, Member
Jana Krit, Member
Nanni Allington, Member
Uri Givon, Member
Ana Presedo, Member
Hei Sook Femke Hagenmaier, Member
Stefana Carp, Member
Kerstin Schneider, Member
Barry Danino, Member
Anja Van Campenhout, Member
Sara Dorman, Member
Ines Maria Balacó Spencer, Member
María Galán Olleros, Member
Julio Duart, Member
Stephanie Böhm, Member
Dan Studer, Member
Audrey Angelliaume, Member
Camilla Bettuzzi, Member
Melinda Witbreuk, Member
Annelie Weinberg, Member
Marco Gotze, Member